Mads H. Andersen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 167 publications

Receptor-defined targeting of a genomically unique melanoma-enriched noncanonical antigen.

Receptor-defined targeting of a genomically unique melanoma-enriched noncanonical antigen.

Journal: Signal transduction and targeted therapy
Published: February 20, 2026

Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cells.

Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cells.

Journal: Signal transduction and targeted therapy
Published: November 28, 2025

Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation.

Immune reconstitution in patients with myelofibrosis conditioned with a non-myeloablative regimen prior to allogeneic stem cell transplantation.

Journal: Bone marrow transplantation
Published: November 19, 2025

Moving for optimal immunity: the effect of acute high-intensity interval training on phenotype, virus specificity and chemokine receptor expression in human CD8+ T cells.

Moving for optimal immunity: the effect of acute high-intensity interval training on phenotype, virus specificity and chemokine receptor expression in human CD8+ T cells.

Journal: Frontiers in immunology
Published: November 04, 2025

Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond.

Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond.

Journal: Signal transduction and targeted therapy
Published: October 21, 2025

Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlates.

Journal: Signal transduction and targeted therapy
Published: September 09, 2025

Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.

Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma.

Journal: The British journal of dermatology
Published: July 01, 2025

Harnessing arginase 2-specific CD8+ T cells to target immunosuppressive cutaneous T-cell lymphoma.

Harnessing arginase 2-specific CD8+ T cells to target immunosuppressive cutaneous T-cell lymphoma.

Journal: The British journal of dermatology
Published: July 01, 2025

Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.

Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma.

Journal: Nature communications
Published: June 19, 2025

TGF-β-specific T cells are frequent in peripheral blood and bone-marrow from patients with myeloproliferative neoplasms.

TGF-β-specific T cells are frequent in peripheral blood and bone-marrow from patients with myeloproliferative neoplasms.

Journal: Leukemia
Published: May 16, 2025

Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer.

Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer.

Journal: Cancer discovery
Published: December 19, 2024

β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.

β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.

Journal: Nature communications
Published: December 16, 2024
Showing 1-12 of 167

Last Updated: 09/26/2026